Usefulness of Combining Galectin-3 and BIVA Assessments in Predicting Short- and Long-Term Events in Patients Admitted for Acute Heart Failure

<table class="table-group" width="800px"><tr class="fig-image" id="a"><td><img alt="983098.fig.003a" src="https://static.hindawi.com/articles/bmri/volume-2014/983098/figures/983098.fig.003a.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(a) </b></td></tr></table></td></tr><tr class="fig-image" id="b"><td><img alt="983098.fig.003b" src="https://static.hindawi.com/articles/bmri/volume-2014/983098/figures/983098.fig.003b.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(b) </b>Kaplan-Meier GAL3 for all events (death + rehospitalization)</td></tr></table></td></tr></table>

<table>Kaplan-Meier for death (a) and events (b) on the basis of GAL3 values greater than 17.8 ng/mL.</table>

BioMed Research International

fig3

Figure 3

Figure 3: Usefulness of Combining Galectin-3 and BIVA Assessments in Predicting Short- and Long-Term Events in Patients Admitted for Acute Heart Failure 

Figure 3 | Usefulness of Combining Galectin-3 and BIVA Assessments in Predicting Short- and Long-Term Events in Patients Admitted for Acute Heart Failure 